Zhi Guo

Hebei Zhiguo Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the large-scale production of active pharmaceutical ingredients (APIs) and chemical intermediates. Established in 1998, the company has grown to become one of the world's largest manufacturers of Metformin Hydrochloride, a foundational treatment for type 2 diabetes. Zhiguo Pharmaceutical operates advanced, GMP-certified manufacturing facilities in Hebei Province and maintains a significant global footprint, exporting products to over 60 countries across Europe, North America, and Asia. In addition to its leadership in the Metformin market, the company produces a range of guanidine-based chemicals and specialty intermediates used in the synthesis of various therapeutic agents. The company is a key supplier to major global generic pharmaceutical firms and is recognized for its high-capacity production and quality standards. Its strategic focus on vertical integration and process optimization has solidified its position as a critical player in the global pharmaceutical supply chain.